Wilson's disease and other neurological copper disorders. - Wikidata - awgldk - TriplyDB

Wilson's disease and other neurological copper disorders.

Wilson's disease and other neurological copper disorders.

http://www.wikidata.org/entity/Q35106874

about

Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine Recent Advances in Photoacoustic Imaging for Deep-Tissue Biomedical Applications.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Neurological features and management of Wilson disease in children: an evaluation of 12 cases Airborne copper exposure in school environments associated with poorer motor performance and altered basal ganglia.Social cognition in Wilson's disease: A new phenotype?Report of the ASFA apheresis registry study on Wilson's disease.Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's disease Current Drug Managements of Wilson's Disease: From West to East.Microbial peptide de-coppers mitochondria: implications for Wilson disease.The sunflower cataract in Wilson's disease: pathognomonic sign or rare finding?Macro- and Microelemental Composition and Toxicity of Unsweetened Natural Cocoa Powder in Sprague-Dawley Rats Diagnostic copper imaging of Menkes disease by synchrotron radiation-generated X-ray fluorescence analysis Neurodevelopmental Deceleration by Urban Fine Particles from Different Emission Sources: A Longitudinal Observational Study.Study of the Serum Copper Levels in Patients with Major Depressive Disorder.Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies.Targeting copper in cancer therapy: 'Copper That Cancer'.Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposure.A novel diagnostic approach to patients with myoclonus.Copper toxicology, oxidative stress and inflammation using zebrafish as experimental model.Optimizing the Readout of Lanthanide-DOTA Complexes for the Detection of Ligand-Bound Copper(I).Stepwise copper(i) binding to metallothionein: a mixed cooperative and non-cooperative mechanism for all 20 copper ions.Copper transporters and chaperones: Their function on angiogenesis and cellular signalling.Bioavailable Trace Metals in Neurological Diseases.Dextromethorphan/Quinidine For Neuropsychiatric Manifestations of Wilson's Disease.Effects of copper toxicity on response inhibition processes: a study in Wilson's disease.Concomitant immune-related events in Wilson disease: implications for monitoring chelator therapy.Restless legs syndrome in Wilson's disease: frequency, characteristics, and mimics.ATP7B expression confers multidrug resistance through drug sequestration Copper Capture in a Thioether-Functionalized Porous Polymer Applied to the Detection of Wilson's Disease.Evaluation of Kayser-Fleischer ring in Wilson disease by anterior segment optical coherence tomography.The double-edged role of copper in the fate of amyloid beta in the presence of anti-oxidants.Recent Updates on Acquired Hepatocerebral Degeneration.Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism.Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease.The genetics of Wilson disease.Mitochondrial Ferredoxin Determines Vulnerability of Cells to Copper Excess.Occupational Metal Exposure and Parkinsonism.Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.The Efficacy and Pharmacological Mechanism of Zn7MT3 to Protect against Alzheimer's Disease.

P2860

Q26863117-039FE137-4E1E-487B-A4C1-D2F1709CE73D Q28072306-93B61F0A-8293-48C9-9217-1437B76E12DE Q30276550-257F079E-B938-43DB-BDF5-87E702040B05 Q33167081-61D0E21D-D009-4EEB-989B-F1F564879EDF Q36004831-02C30924-9951-4108-B957-501C49E072DD Q36337867-CBE269EF-82C2-49B3-979F-20B6FEE2F242 Q36463896-4AF8409F-519F-4728-B66B-1A92940E275E Q36686111-2006A3BF-F34A-451E-A7D7-18A64E9DC5E0 Q36925896-6CA12DE1-B1BB-4D4F-A35E-AEBF0A80549A Q37042204-E10BA845-90C9-44B4-8747-E163CE7723F4 Q37184440-57E3E344-EF59-4199-9704-44CC6246420D Q37219169-D7C49C6A-0CB5-4EB8-98A5-D12DEB58143F Q37257560-E459989A-980A-4144-A63C-459EDF84A92E Q37306135-4523624F-0CA3-4D4E-9B6B-B731576E7C4B Q37385662-0F444CE1-6406-46CB-8E5F-9573C00C3142 Q38362089-5DF1B858-7808-4775-A8F6-0057F005BC8E Q38575035-F217ECCF-1D91-4356-B0CC-43F41B7DBCC3 Q38626063-15783818-DE9C-447D-8D32-3A086D9C9F30 Q38629335-C1F6F1C9-CD97-45B7-9FA3-058DCB0E5700 Q38738079-A89A77C4-DF41-4E00-81F5-702B7BA595C1 Q38785908-AFC3308F-D095-4FA6-BB78-7B647165A5A6 Q38807379-5331A522-AF8E-48E7-9C29-97DC516DF93F Q38942904-73A5791C-6E32-4EF0-A32C-681D20ED1647 Q38967236-942B39A7-311C-455F-8E09-5F5D1B492D3E Q39419865-6F1C222D-CF5C-4588-BE1D-9E27EB2D4AEB Q40464829-35F0ED78-5BB7-4526-8AC6-EFC57562BE32 Q40843017-7287FAC3-425C-4271-8136-38878EE3808F Q40873091-7BF5E668-5FDC-4DDB-AD59-39688DA4587D Q40997062-50789FED-84B4-4B09-9A7B-9436C6BAB219 Q41380169-3874B5BC-FDA6-49D5-9FB1-0AF59D8F833D Q41480062-19EEA9BE-43DF-45A9-A80B-4229A1377ADE Q42210310-A266B8D5-89C9-40E8-930D-8CB79F79B5DD Q42288585-C112FF04-F08F-4EED-9FCD-378D485C8467 Q42315857-AC08526C-AF59-4D38-8B13-CC78563E8E10 Q42367948-27A66567-C265-463A-814B-A8F052B86254 Q42380502-AE82BDF8-96C9-4A22-B731-F93C0C124FBA Q42640010-6A4DB381-1262-428B-9C1D-F7303440DA4E Q46309593-48041AAE-67E7-4C46-B697-EB4BAF0A0E49 Q46309597-C61C4598-8396-4D05-BDF3-EC061CF5BCD4 Q46331404-586997BC-6286-4427-A78C-2718F9F9A165

P2860

Wilson's disease and other neurological copper disorders.

http://www.wikidata.org/entity/Q35106874

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Wilson's disease and other neurological copper disorders.

@ast

Wilson's disease and other neurological copper disorders.

@en

type

label

Wilson's disease and other neurological copper disorders.

@ast

Wilson's disease and other neurological copper disorders.

@en

prefLabel

Wilson's disease and other neurological copper disorders.

@ast

Wilson's disease and other neurological copper disorders.

@en

P1433

Q35106874-FA32F5F8-08BA-4748-9CCF-D434BEF5F883

P1476

Q35106874-43059296-319E-48FE-AD7E-FD56A6070FD9

P2093

Q35106874-9BD25769-8204-4C47-B205-95A223DB52C9

Q35106874-FA87EBE4-4E93-4179-9339-00759711624D

P2860

Q35106874-01C8CEC7-5841-4370-AD4B-D482A563C2E5

Q35106874-0364376F-51F8-49FE-9311-63DCCCD54983

Q35106874-08C090D1-632E-4DD2-8B30-08F86DC93E07

Q35106874-0D39DA72-C7F4-4248-BCAE-1B1F93273796

Q35106874-0FAF580A-880A-41AC-8D4F-9681B0EBB402

Q35106874-11AC3276-BC20-4B17-B821-FDA35A7F665E

Q35106874-14DAD4B1-35DF-4D19-8E27-7706C8C9E4B3

Q35106874-15851F15-EA0E-433B-B4D4-D75198ED28B5

Q35106874-161C91BC-0E58-44D1-8B49-F1EEE3CC2907

Q35106874-167C9C21-7C98-40B6-AD9F-EB9C90FB9FBC

P304

Q35106874-AA44146F-C865-4C87-9F8E-44B65265DE61

P31

Q35106874-9BDC5561-D418-4F1B-9D85-04A58FFE631E

P356

Q35106874-DB820CE0-056A-42DF-B432-CAAC8C3E5B94

P433

Q35106874-7C74C50D-7067-49E8-A35E-A0B2754009E7

P478

Q35106874-79CA0068-9FD1-47E4-BD96-5BF546DFAEB2

P50

Q35106874-61720D1E-B56D-4FB3-94EF-439CEBA12883

P577

Q35106874-D763C6B5-C546-4F35-9DE0-109FC8024140

P698

Q35106874-821BC47E-1B86-4962-A461-18FFA3F1ED44

P932

Q35106874-FA3F21E9-7D99-4746-A592-9B97E2D4EEEC

P356

S1474-4422(14)70190-5

P1433

Lancet Neurology

P1476

Wilson's disease and other neurological copper disorders.

@en

P2093

Karl Heinz Weiss

http://www.w3.org/2001/XMLSchema#string

Stephen G Kaler

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man

The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene

Neonatal diagnosis and treatment of Menkes disease

Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance

Exome sequencing reveals VCP mutations as a cause of familial ALS

Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy

Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine

ATP7A-related copper transport diseases-emerging concepts and future trends

P304

103-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(14)70190-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Oliver Bandmann

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25496901

http://www.w3.org/2001/XMLSchema#string

P932

4336199

http://www.w3.org/2001/XMLSchema#string